Table of Content - Knee Osteoarthritis Market

The global knee osteoarthritis market is estimated to be valued at USD 9,228.4 Mn in 2026 and is expected to reach USD 19,842.3 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 11.6% from 2026 to 2033. Knee osteoarthritis (OA) is a progressive joint disease that slowly destroys the knee's cartilage causing pain, stiffness, swelling and limited movement. Knee osteoarthritis is one of the most common musculoskeletal diseases in the world and its prevalence is increasing due to ageing populations, obesity, sports injuries and sedentary lifestyles.

The knee osteoarthritis market is characterized by multiple segments such as medications for joint pain and inflammation, joint injections and visco supplements, orthotic aids, physiotherapies and a wide spectrum of surgical knee osteoarthritis treatment including knee replacement surgery. The market is witnessing growing interest in regenerative therapies, including platelet-rich plasma (PRP), stem cell therapies, and disease-modifying osteoarthritis drugs (DMOADs), supported by rising healthcare expenditure and continuous advancements in orthopedic care.

Market Dynamics

The global knee osteoarthritis market is driven by growing aging population, increasing prevalence of obesity, and growing incidence of joint injuries leading to a larger patient pool that needs long-term treatment. Growing awareness for early diagnosis, improving access to cutting-edge imaging technologies, and increasing investments in disease-modifying osteoarthritis drugs (DMOADs), biologics, and minimally invasive therapies are further contributing to the market growth.

However, a number of constraints are present in the market, such as high cost of advanced therapies and knee replacement procedures, limited reimbursement in developing countries, and lack of widely approved disease-modifying treatments. Nevertheless, expanding use of regenerative medicine modalities like stem cell and platelet-rich plasma (PRP) therapies, coupled with the implementation of AI-enabled diagnostics and digital health solutions will offer new opportunities for growth in knee osteoarthritis market.

Key Features of the Study

This report provides in-depth analysis of the global knee osteoarthritis market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global knee osteoarthritis market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Eli Lilly and Company, Sanofi, Bayer AG, GSK plc, Novartis AG, AbbVie Inc., Merck & Co., Inc., Johnson & Johnson, and Anika Therapeutics, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global knee osteoarthritis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global knee osteoarthritis market

Market Segmentation

Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
- Hyaluronic acid
- Non-steroidal anti-inflammatory drugs (NSAIDs)
- Analgesics
- Corticosteroid
- Others
Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Oral
- Parenteral
- Others
Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Pfizer Inc.
- Eli Lilly and Company
- Sanofi
- Bayer AG
- GSK plc
- Novartis AG
- AbbVie Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- Anika Therapeutics, Inc.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Knee Osteoarthritis Market, By Drug Type
  - Global Knee Osteoarthritis Market, By Route of Administration
  - Global Knee Osteoarthritis Market, By Distribution Channel
  - Global Knee Osteoarthritis Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
Global Knee Osteoarthritis Market, By Drug Type, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hyaluronic acid
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Non-steroidal anti-inflammatory drugs (NSAIDs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Analgesics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Corticosteroid
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Knee Osteoarthritis Market, By Route of Administration, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Parenteral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Knee Osteoarthritis Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Knee Osteoarthritis Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Anika Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘Knee Osteoarthritis Market' - Global forecast to 2033

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

KNEE OSTEOARTHRITIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Need a Custom Report?

EXISTING CLIENTELE